A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT01292603 · COMPLETED
Trial details
- NCT number
- NCT01292603
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-18
- Primary completion
- 2014-05-07
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.